✦ LIBER ✦
The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers
✍ Scribed by P. Kelly Marcom; Claudine Isaacs; Lyndsay Harris; Zee Wang Wong; Aruna Kommarreddy; Nellie Novielli; Gretchen Mann; Yu Tao; Matthew J. Ellis
- Publisher
- Springer US
- Year
- 2006
- Tongue
- English
- Weight
- 144 KB
- Volume
- 102
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.